• Filing Date: 2018-05-10
  • Form Type: 10-Q
  • Description: Quarterly report
v3.8.0.1
Stock-based Compensation - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Jun. 27, 2017
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options outstanding (in shares)   239,000   542,102  
Options outstanding, weighted average price (in dollars per share)   $ 6.94   $ 8.75  
Options outstanding, weighted average remaining contractual term   2 years 68 days   1 year 3 months 30 days  
Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation not yet recognized   $ 0      
Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock based compensation not yet recognized   $ 601,000      
Stock granted (in shares)   100,000      
Shares forfeited (in shares)   20,000      
Shares pending vesting (in shares)   2,182,522   2,102,522  
Stock vested (in shares)   0      
Restricted Stock | Directors and Certain Employees          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ 73,000 $ 139,000    
Restricted Stock | Directors          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Aggregate intrinsic value   $ 3,000      
Options outstanding, weighted average remaining contractual term   3 months 26 days      
Restricted Stock | Certain Employees          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Aggregate intrinsic value   $ 24,000      
Options outstanding, weighted average remaining contractual term   1 month 53 days      
Omnibus Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Additional shares of common stock authorized for issuance (in shares) 9,900,000        
Shares of common stock reserved for issuance (in shares) 12,600,000        
Omnibus Plan | Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ 0 0    
Options outstanding (in shares)   239,000      
Options outstanding, weighted average price (in dollars per share)   $ 6.94      
Omnibus Plan | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares pending vesting (in shares)   2,182,522      
Omnibus Plan | Restricted Stock | Directors          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock granted (in shares)   233,215      
Omnibus Plan | Restricted Stock | Directors | 2016 Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ 0 60,000    
Stock granted (in shares)         65,212
Stock vesting period         1 year
Restricted stock, aggregate intrinsic value         $ 255,000
Omnibus Plan | Restricted Stock | Directors | 2017 Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ 0      
Stock granted (in shares)       51,132  
Stock vesting period   1 year      
Restricted stock, aggregate intrinsic value       $ 17,000  
Stock vested (in shares)       42,610  
Omnibus Plan | Restricted Stock | Certain Employees          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock granted (in shares)   8,522      
Omnibus Plan | Restricted Stock | Certain Employees | 2016 Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ (18,000) $ 79,000    
Stock granted (in shares)         200,000
Stock vesting period         2 years
Restricted stock, aggregate intrinsic value         $ 674,000
Shares forfeited (in shares)   20,000      
Shares pending vesting (in shares)   74,000      
Omnibus Plan | Restricted Stock | Certain Employees | 2017 Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ 90,000      
Stock vesting period   2 years      
Restricted stock, aggregate intrinsic value       $ 745,000  
Shares pending vesting (in shares)       2,000,000  
Aggregate intrinsic value   $ 760,000      
Options outstanding, weighted average remaining contractual term   17 months 78 days      
Omnibus Plan | Restricted Stock | Certain Employees | 2018 Grant          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (income)   $ 1,000      
Restricted stock, aggregate intrinsic value   $ 39,000      
Shares pending vesting (in shares)   100,000      
Aggregate intrinsic value   $ 38,000      
Options outstanding, weighted average remaining contractual term   28 months 36 days      
Omnibus Plan | Restricted Stock | Certain Employees | 2018 Grant | Vesting in two years          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock vesting period   2 years      
Shares pending vesting (in shares)   50,000      
Omnibus Plan | Restricted Stock | Certain Employees | 2018 Grant | Vesting in three years          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock vesting period   3 years      
Shares pending vesting (in shares)   50,000